title: Antiprothrombin antibodies--are they worth assaying?
abstract: According to the preliminary classification criteria of the antiphospholipid syndrome (APS) (Sapporo Criteria), beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies (aCL) and lupus anticoagulant (LA) are the only laboratory tests considered as criteria for the classification of the APS. Recently, antibodies against phosphatidylserine-prothrombin complex (aPS/PT) have been detected and these antibodies, rather than antibodies against prothrombin alone, are closely associated with APS and LA. We assessed the sensitivity and specificity of aPS/PT for the diagnosis of APS in our population of patients with a variety of autoimmune disorders and investigated whether aPS/PT could be used as diagnostic test in patients suspected of having APS. The study population comprised 219 patients with autoimmune diseases including 82 patients with APS and 137 without APS (55 systemic lupus erythematosus, 32 rheumatoid arthritis, 10 primary Sjogren's syndrome, 8 scleroderma, 5 Behcet's disease and 27 other rheumatic diseases). IgG/M aPS/PT were measured by ELISA using phosphatidylserine-prothrombin complex as antigen immobilized on ELISA plates in the presence of CaCl2. IgG/M aCL were measured by standard methods and LA was detected by clotting assays. aPS/PT, aCL and LA were more frequently found in patients with APS (47, 46 and 69, respectively) than in those without APS (11, 19 and 29, respectively) (OR 95% [CI]; 15.4 [7.2-32.7], 7.9 [4.1-15.2, 19.8 [9.6-40.6], respectively]. The sensitivity of each assay for the diagnosis of APS was 57%, 56% and 86% with a specificity of 92%, 86% and 79%, respectively. aPS/PT and aCL have similar diagnostic value for APS, therefore, we propose that aPS/PT should be further explored, not only for research purposes, but also as a candidate of one of the laboratory criteria for the classification of the APS.
authors.affiliation: Department of Medicine II, Hokkaido University Graduate School of Medicine, N15 W7, Kita-ku, Sapporo 060-8638, Japan. at3tat@med.hokudai.ac.jp
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Atsumi
authors.forename: Olga
authors.initials: O
authors.lastname: Amengual
authors.forename: Shinsuke
authors.initials: S
authors.lastname: Yasuda
authors.forename: Takao
authors.initials: T
authors.lastname: Koike
mesh_terms: D017152:Antibodies, Antiphospholipid / Q000737:chemistry; D016736:Antiphospholipid Syndrome / Q000276:immunology; D001323:Autoantibodies / Q000737:chemistry*; D002624:Chemistry, Clinical / Q000379:methods*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000737:chemistry; D008297:Male; D011247:Pregnancy; D011516:Prothrombin / Q000737:chemistry* / Q000276:immunology*; D012680:Sensitivity and Specificity
chemical_list: D017152:Antibodies, Antiphospholipid; D001323:Autoantibodies; D007074:Immunoglobulin G; D011516:Prothrombin